| CTN |
NIDA-CTN-0067 |
Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up |
P. Todd Korthuis, MD |
|
| CTN |
NIDA-CTN-0068 |
Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) |
Madhukar H. Trivedi, M.D. |
|
| CTN |
NIDA-CTN-0053 |
Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT) |
Kevin M. Gray, MD |
|
| DTMC |
NIDA-CSP-1019 |
Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System For The Treatment Of Cocaine Dependence |
Ahmed Elkashef, M.D., Paul J. Fudala, Ph.D. |
|
| DTMC |
NIDA-CSP-1020 |
A Phase III Placebo-Controlled, Double-Blind Multi-Site Trial of Lofexidine for Opiate Withdrawal |
Ann Montgomery, R.N. |
|
| DTMC |
NIDA-CSP-1018 |
A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence |
Walter Ling, M.D., Paul J. Fudala, Ph.D., Paul Casadonte, M.D. |
|
| DTMC |
NIDA-CSP-1008B |
A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence |
Peter Bridge, M.D. |
|
| DTMC |
NIDA-CSP-1008A |
A Multicenter Efficacy/Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence |
Peter Bridge, M.D., Paul J. Fudala, Ph.D. |
|
| DTMC |
NIDA-CSP-999 |
A Multicenter Clinical Trial of Buprenorphine in Treatment of Opiate Dependence |
Walter Ling, M.D., Donald R. Wesson, M.D., C. James Klett, Ph.D. |
|
